Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Acute Myocarditis (ARGO)
NCT05855746Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2024
- Primary completion
- Jan 2028
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in acute myocarditis, sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2024; status: recruiting.
02
Drugs
colchicine
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on NCT05855746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05855746.